STOCK TITAN

[Form 4] Galecto, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Galecto, Inc. (GLTO) – Form 4 insider transaction

Interim CFO Lori Firmani settled 374 restricted stock units (RSUs) on 07/03/2025, receiving an equivalent number of common shares. To satisfy withholding taxes associated with the vesting, 147 shares were automatically sold at $3.39 per share under the company’s 2020 Equity Incentive Plan, a non-discretionary sale required by plan rules. After the transactions, Firmani directly holds 692 common shares and 1,100 unvested/settled RSUs. The filing reflects routine equity compensation activity and does not signal a strategic change in insider ownership.

Galecto, Inc. (GLTO) – Transazione interna Form 4

La CFO ad interim Lori Firmani ha liquidato 374 unità di azioni ristrette (RSU) il 03/07/2025, ricevendo un numero equivalente di azioni ordinarie. Per coprire le tasse di ritenuta associate al vesting, 147 azioni sono state automaticamente vendute a 3,39$ per azione secondo il Piano di Incentivi Azionari 2020 della società, una vendita non discrezionale richiesta dalle regole del piano. Dopo le transazioni, Firmani detiene direttamente 692 azioni ordinarie e 1.100 RSU non maturate/liquidate. La comunicazione riflette un’attività di compensazione azionaria di routine e non indica un cambiamento strategico nella proprietà interna.

Galecto, Inc. (GLTO) – Transacción interna Formulario 4

La CFO interina Lori Firmani liquidó 374 unidades restringidas de acciones (RSU) el 03/07/2025, recibiendo un número equivalente de acciones comunes. Para cubrir los impuestos retenidos asociados con la consolidación, se vendieron automáticamente 147 acciones a $3.39 por acción bajo el Plan de Incentivos de Capital 2020 de la empresa, una venta no discrecional requerida por las reglas del plan. Tras las transacciones, Firmani posee directamente 692 acciones comunes y 1,100 RSU no consolidadas/liquidadas. La presentación refleja una actividad rutinaria de compensación accionaria y no indica un cambio estratégico en la propiedad interna.

Galecto, Inc. (GLTO) – 내부자 거래 신고서(Form 4)

임시 CFO 로리 퍼마니는 2025년 7월 3일에 374개의 제한 주식 단위(RSU)를 정산하여 동일 수량의 보통주를 받았습니다. 베스팅에 따른 원천징수세를 충당하기 위해 회사의 2020년 주식 인센티브 계획에 따라 147주가 주당 $3.39에 자동 매도되었으며, 이는 계획 규칙에 의해 요구되는 비재량적 매도입니다. 거래 후 퍼마니는 직접 692주의 보통주와 1,100개의 미베스트/정산된 RSU를 보유하고 있습니다. 이번 신고는 정기적인 주식 보상 활동을 반영하며 내부자 소유권의 전략적 변화 신호는 아닙니다.

Galecto, Inc. (GLTO) – Transaction d’initié Formulaire 4

La CFO intérimaire Lori Firmani a réglé 374 unités d’actions restreintes (RSU) le 03/07/2025, recevant un nombre équivalent d’actions ordinaires. Pour couvrir les taxes à la source liées à l’acquisition, 147 actions ont été automatiquement vendues à 3,39$ par action dans le cadre du Plan d’Incitation en Actions 2020 de la société, une vente non discrétionnaire exigée par les règles du plan. Après ces transactions, Firmani détient directement 692 actions ordinaires et 1 100 RSU non acquises/réglées. Ce dépôt reflète une activité de rémunération en actions courante et ne signale pas de changement stratégique dans la détention des initiés.

Galecto, Inc. (GLTO) – Insider-Transaktion Form 4

Die interimistische CFO Lori Firmani hat am 03.07.2025 374 Restricted Stock Units (RSUs) abgewickelt und dafür eine entsprechende Anzahl Stammaktien erhalten. Zur Begleichung der Quellensteuern im Zusammenhang mit der Vesting-Phase wurden 147 Aktien automatisch zu je 3,39$ im Rahmen des Aktienanreizplans 2020 des Unternehmens verkauft, ein nicht diskretionärer Verkauf, der durch die Planregeln vorgeschrieben ist. Nach den Transaktionen hält Firmani direkt 692 Stammaktien und 1.100 nicht ausgeübte/abgewickelte RSUs. Die Meldung spiegelt eine routinemäßige Aktienvergütungsaktivität wider und signalisiert keine strategische Änderung der Insiderbeteiligung.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting with minor tax sale; negligible impact on GLTO valuation.

The Form 4 shows an automatic RSU settlement and tax-related sale by Interim CFO Lori Firmani. The net disposition is just 147 shares (<0.1% of shares outstanding), executed at $3.39 per share. Because the sale was mandated by the incentive plan, it provides little insight into management’s sentiment. Post-transaction ownership increases modestly through the vested shares while maintaining a sizable RSU balance (1,100 units) that further aligns the executive’s incentives with shareholders. Overall, the event is administratively important for compliance but not financially material to investors.

Galecto, Inc. (GLTO) – Transazione interna Form 4

La CFO ad interim Lori Firmani ha liquidato 374 unità di azioni ristrette (RSU) il 03/07/2025, ricevendo un numero equivalente di azioni ordinarie. Per coprire le tasse di ritenuta associate al vesting, 147 azioni sono state automaticamente vendute a 3,39$ per azione secondo il Piano di Incentivi Azionari 2020 della società, una vendita non discrezionale richiesta dalle regole del piano. Dopo le transazioni, Firmani detiene direttamente 692 azioni ordinarie e 1.100 RSU non maturate/liquidate. La comunicazione riflette un’attività di compensazione azionaria di routine e non indica un cambiamento strategico nella proprietà interna.

Galecto, Inc. (GLTO) – Transacción interna Formulario 4

La CFO interina Lori Firmani liquidó 374 unidades restringidas de acciones (RSU) el 03/07/2025, recibiendo un número equivalente de acciones comunes. Para cubrir los impuestos retenidos asociados con la consolidación, se vendieron automáticamente 147 acciones a $3.39 por acción bajo el Plan de Incentivos de Capital 2020 de la empresa, una venta no discrecional requerida por las reglas del plan. Tras las transacciones, Firmani posee directamente 692 acciones comunes y 1,100 RSU no consolidadas/liquidadas. La presentación refleja una actividad rutinaria de compensación accionaria y no indica un cambio estratégico en la propiedad interna.

Galecto, Inc. (GLTO) – 내부자 거래 신고서(Form 4)

임시 CFO 로리 퍼마니는 2025년 7월 3일에 374개의 제한 주식 단위(RSU)를 정산하여 동일 수량의 보통주를 받았습니다. 베스팅에 따른 원천징수세를 충당하기 위해 회사의 2020년 주식 인센티브 계획에 따라 147주가 주당 $3.39에 자동 매도되었으며, 이는 계획 규칙에 의해 요구되는 비재량적 매도입니다. 거래 후 퍼마니는 직접 692주의 보통주와 1,100개의 미베스트/정산된 RSU를 보유하고 있습니다. 이번 신고는 정기적인 주식 보상 활동을 반영하며 내부자 소유권의 전략적 변화 신호는 아닙니다.

Galecto, Inc. (GLTO) – Transaction d’initié Formulaire 4

La CFO intérimaire Lori Firmani a réglé 374 unités d’actions restreintes (RSU) le 03/07/2025, recevant un nombre équivalent d’actions ordinaires. Pour couvrir les taxes à la source liées à l’acquisition, 147 actions ont été automatiquement vendues à 3,39$ par action dans le cadre du Plan d’Incitation en Actions 2020 de la société, une vente non discrétionnaire exigée par les règles du plan. Après ces transactions, Firmani détient directement 692 actions ordinaires et 1 100 RSU non acquises/réglées. Ce dépôt reflète une activité de rémunération en actions courante et ne signale pas de changement stratégique dans la détention des initiés.

Galecto, Inc. (GLTO) – Insider-Transaktion Form 4

Die interimistische CFO Lori Firmani hat am 03.07.2025 374 Restricted Stock Units (RSUs) abgewickelt und dafür eine entsprechende Anzahl Stammaktien erhalten. Zur Begleichung der Quellensteuern im Zusammenhang mit der Vesting-Phase wurden 147 Aktien automatisch zu je 3,39$ im Rahmen des Aktienanreizplans 2020 des Unternehmens verkauft, ein nicht diskretionärer Verkauf, der durch die Planregeln vorgeschrieben ist. Nach den Transaktionen hält Firmani direkt 692 Stammaktien und 1.100 nicht ausgeübte/abgewickelte RSUs. Die Meldung spiegelt eine routinemäßige Aktienvergütungsaktivität wider und signalisiert keine strategische Änderung der Insiderbeteiligung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Firmani Lori

(Last) (First) (Middle)
OLE MAALOES VEJ 3
C/O GALECTO, INC.

(Street)
COPENHAGEN N G7 G7 DK-2200

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Galecto, Inc. [ GLTO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Interim CFO
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/03/2025 M 374 A (1) 839 D
Common Stock 07/03/2025 S(2) 147 D $3.39 692 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 07/03/2025 M 374 (3) (3) Common Stock 374 $0 1,100 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
2. Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person.
3. This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date.
/s/ Lori Firmani 07/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Galecto Inc.

NASDAQ:GLTO

GLTO Rankings

GLTO Latest News

GLTO Latest SEC Filings

GLTO Stock Data

4.68M
1.27M
3.46%
13.05%
1.39%
Biotechnology
Pharmaceutical Preparations
Link
Denmark
BOSTON